174 related articles for article (PubMed ID: 33803298)
1. Structure and Distribution of Health Care Costs across Age Groups of Patients with Multimorbidity in Lithuania.
Nedzinskienė L; Jurevičienė E; Visockienė Ž; Ulytė A; Puronaitė R; Kasiulevičius V; Kazėnaitė E; Burneikaitė G; Navickas R
Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33803298
[TBL] [Abstract][Full Text] [Related]
2. Does multimorbidity still remain a matter of the elderly: Lithuanian national data analysis.
Jurevičienė E; Onder G; Visockienė Ž; Puronaitė R; Petrikonytė D; Gargalskaitė U; Kasiulevičius V; Navickas R
Health Policy; 2018 Jun; 122(6):681-686. PubMed ID: 29602577
[TBL] [Abstract][Full Text] [Related]
3. Improving the performance of social health insurance system through increasing outpatient expenditure reimbursement ratio: a quasi-experimental evaluation study from rural China.
Miao Y; Gu J; Zhang L; He R; Sandeep S; Wu J
Int J Equity Health; 2018 Jun; 17(1):89. PubMed ID: 29940956
[TBL] [Abstract][Full Text] [Related]
4. Multimorbidity, health care utilization and costs in an elderly community-dwelling population: a claims data based observational study.
Bähler C; Huber CA; Brüngger B; Reich O
BMC Health Serv Res; 2015 Jan; 15():23. PubMed ID: 25609174
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and structure of multiple chronic conditions in Lithuanian population and the distribution of the associated healthcare resources.
Navickas R; Visockienė Ž; Puronaitė R; Rukšėnienė M; Kasiulevičius V; Jurevičienė E
Eur J Intern Med; 2015 Apr; 26(3):160-8. PubMed ID: 25726495
[TBL] [Abstract][Full Text] [Related]
6. Physical multimorbidity, health service use, and catastrophic health expenditure by socioeconomic groups in China: an analysis of population-based panel data.
Zhao Y; Atun R; Oldenburg B; McPake B; Tang S; Mercer SW; Cowling TE; Sum G; Qin VM; Lee JT
Lancet Glob Health; 2020 Jun; 8(6):e840-e849. PubMed ID: 32446349
[TBL] [Abstract][Full Text] [Related]
7. Smoking-Attributable Direct Healthcare Expenditure in Lithuania: A Prevalence-Based Annual Cost Approach.
Liutkutė V; Štelemėkas M; Veryga A
Medicina (Kaunas); 2018 Apr; 54(2):. PubMed ID: 30344246
[No Abstract] [Full Text] [Related]
8. Hong Kong domestic health spending: financial years 1989/90 to 2008/09.
Tin KY; Tsoi PK; Lee YH; Tsui EL; Lam DW; Chui AW; Lo SV
Hong Kong Med J; 2012 Aug; 18(4 Suppl 4):1-23. PubMed ID: 22947491
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and costs of multimorbidity by deprivation levels in the basque country: a population based study using health administrative databases.
Orueta JF; García-Álvarez A; García-Goñi M; Paolucci F; Nuño-Solinís R
PLoS One; 2014; 9(2):e89787. PubMed ID: 24587035
[TBL] [Abstract][Full Text] [Related]
10. Multimorbidity combinations, costs of hospital care and potentially preventable emergency admissions in England: A cohort study.
Stokes J; Guthrie B; Mercer SW; Rice N; Sutton M
PLoS Med; 2021 Jan; 18(1):e1003514. PubMed ID: 33439870
[TBL] [Abstract][Full Text] [Related]
11. Economic burden of multimorbidity among older adults: impact on healthcare and societal costs.
Picco L; Achilla E; Abdin E; Chong SA; Vaingankar JA; McCrone P; Chua HC; Heng D; Magadi H; Ng LL; Prince M; Subramaniam M
BMC Health Serv Res; 2016 May; 16():173. PubMed ID: 27160080
[TBL] [Abstract][Full Text] [Related]
12. The impact of multimorbidity among adults with cardiovascular diseases on healthcare costs in Indonesia: a multilevel analysis.
Ramadani RV; Svensson M; Hassler S; Hidayat B; Ng N
BMC Public Health; 2024 Mar; 24(1):816. PubMed ID: 38491478
[TBL] [Abstract][Full Text] [Related]
13. [Estimated average yearly treatment expenditures for hemodialysis patients (data of Kaunas University of Medicine Hospital in the year 2005)].
Vaiciūniene R; Kuzminskis V; Sribikiene B; Petruliene K; Dvaranauskaite L
Medicina (Kaunas); 2007; 43 Suppl 1():85-9. PubMed ID: 17551283
[TBL] [Abstract][Full Text] [Related]
14. Multimorbidity healthcare expenditure in Belgium: a 4-year analysis (COMORB study).
Tran PB; Nikolaidis GF; Abatih E; Bos P; Berete F; Gorasso V; Van der Heyden J; Kazibwe J; Tomeny EM; Van Hal G; Beutels P; van Olmen J
Health Res Policy Syst; 2024 Mar; 22(1):35. PubMed ID: 38519938
[TBL] [Abstract][Full Text] [Related]
15. Short-term persistence of high health care costs in a nationally representative sample of children.
Liptak GS; Shone LP; Auinger P; Dick AW; Ryan SA; Szilagyi PG
Pediatrics; 2006 Oct; 118(4):e1001-9. PubMed ID: 17015496
[TBL] [Abstract][Full Text] [Related]
16. Effect of multimorbidity on utilisation and out-of-pocket expenditure in Indonesia: quantile regression analysis.
Anindya K; Ng N; Atun R; Marthias T; Zhao Y; McPake B; van Heusden A; Pan T; Lee JT
BMC Health Serv Res; 2021 May; 21(1):427. PubMed ID: 33952273
[TBL] [Abstract][Full Text] [Related]
17. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
Rothbard AB; Lee S; Blank MB
J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
[TBL] [Abstract][Full Text] [Related]
18. Relationship between multimorbidity and direct healthcare costs in an advanced elderly population. Results of the PRISCUS trial.
Nagl A; Witte J; Hodek JM; Greiner W
Z Gerontol Geriatr; 2012 Feb; 45(2):146-54. PubMed ID: 22350393
[TBL] [Abstract][Full Text] [Related]
19. Association between multimorbidity patterns and healthcare costs among middle-aged and older adults in China.
Zhao X; Zhang Q; Ma C; Liu H; Chen Y
Arch Gerontol Geriatr; 2023 Jun; 109():104959. PubMed ID: 36804649
[TBL] [Abstract][Full Text] [Related]
20. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
